October 28, 2024
This study presents a proof-of-principle pipeline to build personalized digital cardiac twins by integrating cardiovascular MRI and electrocardiographic
July 5, 2024
The EU-funded research consortium on virtual human twins for a more effective and personalized treatment of complex cardiovascular
May 30, 2024
By simulating human organs, companies like ELEM Biotech can predict how patients will respond to various treatments, thus enhancing safety and
April 29, 2024
In this study, we present a systematic evaluation of CRT pacing protocols through an in silico clinical trial based on a patient-specific digital twin cohort of Left Bundle Branch Block (LBBB)
April 18, 2024
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. While current computational methodologies focus on predicting the incidence of proarrhythmic events after drug administration, the objective of
February 28, 2024
A development by the Barcelona Supercomputing Center and ELEM Biotech allows the creation of a digital twin of a heart and the simulation of its function over time, and its reaction to various
February 28, 2024
The Barcelona Supercomputing Center (BSC) and the spin-off Elem Biotech are working to create digital humans with the aim of advancing personalized medicine to prevent and treat diseases more
February 27, 2024
It is what they call a ‘digital twin’ , the most revolutionary prototype in the field of health that has been presented at the Mobile World Congress in Barcelona these days by
February 27, 2024
“It can anticipate the results of different therapies in patients with cardiac problems, but it can also detect possible future diseases in patients without them,” explains Mariano
February 27, 2024
ELEM Biotech’s CTO, Mariano Vázquez, was interviewed by GEN – Genetic Engineering & Biotechnology This ‘replicating heart’ presented this Tuesday at the MWCapital stand, with the
February 27, 2024
At the Mobile World Congress (MWC), ELEM Biotech, in collaboration with the Barcelona Supercomputing Center (BSC), presented a “replicating heart” prototype. “This is not the future—it is
February 27, 2024
ELEM Biotech’s CEO, Christopher Morton, explained to El Periódico how the company develops digital replicas of human organs, including the heart. These digital twins allow simulation of